CCND1 and thyroid gland carcinoma: De Falco et al. reported that CD44-ICD enhances the expression of cyclin D1 by promoting CREB recruitment to the cyclin D1 promoter and upregulating the transcription of cyclin D1, leading to the acceleration of cell proliferation in thyroid carcinoma [72,114].